This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Unilateral Primary Osteoarthritis of Knee
and you are
between 45 and 80
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine whether Extracorporeal Focused Shock Wave Therapy reduces knee pain and enhance function in patients with primary knee osteoarthritis.

Provided treatments

  • Device: Extracorporeal Shock Waves
  • Device: Sham Extracorporeal Shock Waves
  • Other: Physical activities

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02904785. The sponsor of the trial is University of Sao Paulo General Hospital and it is looking for 30 volunteers for the current phase.
Official trial title:
The Efficacy of Extracorporeal Focused Shock Wave Therapy for Patients With Primary Knee Osteoarthritis